Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3Unknown 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 11Lymphoid 10Thoracic 3CNS 3Gynecologic 1

Conditions

Neuroblastoma 3

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Vindesine × CNS × Clear all
NCT03042429 2017-02-06

NB2004-HR

University of Cologne

Phase 3 Completed
360 enrolled
CNS

Neuroblastoma

NCT00002802 2013-12-19

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Completed
500 enrolled
CNS

Neuroblastoma

NCT00017225 2013-08-02

Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡